This technical information has been contributed by
Enable Injections and Flex Partner for Production of Wearable, High Volume Injectors
CINCINNATI—Enable Injections Inc., a developer and manufacturer of wearable medical devices that enable easy patient self-administration of high volume injectable drugs, has entered into a product development and manufacturing partnership with Flex, a global company that designs and builds intelligent, connected products.
As part of the deal, Enable Injections and Flex will collaborate on the design, development, and production of customized wearable injector systems for pharmaceutical company products and clinical trials.
“Effective design of wearable medical devices requires that we innovate on multiple fronts, pushing the boundaries of wearable technology, medical device development, and manufacturing processes,” said Paul Humphries, president of High Reliability Solutions at Flex, in a press release. “With their track record of quality and innovation, Enable Injections is an ideal partner in this process. We are proud to have been selected as Enable Injections’ manufacturing partner, and thrilled to be helping bring innovative, high quality wearable medical devices to the pharmaceutical and biotech industries.”
According to Enable Injections, the company’s novel injectors—based on pain-free injection technology and preferred by patient panels—provide customers with numerous advantages, including subcutaneous delivery of up to 50 mL doses of high volume and/or viscous biologics, as well as the ability to monitor compliance and capture data utilizing optional Bluetooth connectivity and a mobile app to provide “a connected healthcare solution.” Additional benefits are reported to include passive warming of drug product, eliminating the 30-minute wait for refrigerated vials to reach room temperature; automated mixing and reconstitution, reducing formulation time and drug development costs; use of standard vials, cartridges, syringes, and existing container closures; and facilitation of in-home therapy, reducing healthcare system costs.
“Flex is the recognized leader in high volume manufacturing of body-worn injection systems,” said Michael D. Hooven, president and CEO of Enable Injections, in the release. “We very much look forward to partnering with Flex to satisfy pharmaceutical and biotech company requirements for high reliability, high volume manufacturing.
|Home | About Us | Back To Technical Library | Contact Us|
Copyright © 1996-2010 JobShop.com. All Rights Reserved.
General or Technical Questions? E-mail support@JobShop.com